KP Tissue (TSE:KPT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
KP Tissue Inc. reported robust financial results with a record $1.9 billion in sales and a significant increase in Adjusted EBITDA for the fiscal year 2023, alongside a solid Q4 performance boasting a 37.9% rise in Adjusted EBITDA and a slight increase in net income. The company’s growth was fueled by market share gains in the Consumer segment, strategic investments, and operational efficiency. KP Tissue is poised to continue this momentum into 2024, expecting stable margins and sustained EBITDA in Q1.
For further insights into TSE:KPT stock, check out TipRanks’ Stock Analysis page.
